Genitourinary Cancers

Latest News

A World of Research, Care, and Science: Becoming A Radiation Oncologist
A World of Research, Care, and Science: Becoming A Radiation Oncologist

March 12th 2025

James B. Yu, MD, MHS, FASTRO, didn’t always envision himself as a radiation oncologist, but now works tirelessly to treat patients and advance research for genitourinary cancers.

Data presented at 2025 ASCO GU reinforce the use of agents like nivolumab, cabozantinib, and darolutamide across different genitourinary malignancies.
Top 5 Takeaways for Genitourinary Cancer Care From 2025 ASCO GU

February 21st 2025

Positive Efficacy Noted With Cemiplimab/Chemotherapy in Penile Carcinoma
Positive Efficacy Noted With Cemiplimab/Chemotherapy in Penile Carcinoma

February 15th 2025

Promising Clinical Activity in UTUC Lesions With Enfortumab Vedotin Plus Pembrolizumab
Promising Clinical Activity in UTUC Lesions With Enfortumab Vedotin Plus Pembrolizumab

February 14th 2025

The 2025 Genitourinary Cancers Symposium will feature key updates in the management of different bladder, prostate, and kidney cancer populations.
A Look at Upcoming Impactful Presentations at ASCO GU 2025

February 12th 2025

Video Series
Video Interviews
Podcasts
Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.
Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.

More News